Jonathan R. Lai
20Patents
2h-index
24Co-inventors
57Inventor score
Filing activity: Mar 14, 2003 → Apr 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6958384B2 | Polypeptides containing γ-amino acids | Emerging Cross-Sectional Technologies | 15 | Expired |
| US9346875B2 | Therapy for filovirus infection | Chemistry; Metallurgy | 9 | Active |
| US10081669B2 | Therapy for filovirus infection | Chemistry; Metallurgy | 2 | Active |
| US10875907B2 | Filovirus antibody | Chemistry; Metallurgy | 2 | Active |
| US10391171B2 | Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins | Chemistry; Metallurgy | 2 | Active |
| US10377815B2 | Bispecific antibodies and fusion proteins that bind to EBOV and NPC1 | Chemistry; Metallurgy | 1 | Active |
| US11135292B2 | Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins | Chemistry; Metallurgy | 1 | Active |
| US12186383B2 | Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11174308B2 | Synthetic antibodies to BAX and uses thereof | Physics | 0 | Active |
| US11643455B2 | High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US10772949B2 | Dengue virus glycoprotein E DIII variants and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11149080B2 | Methods of treating filovirus infections utilizing bispecific antibodies and fusion proteins that bind EBOV and NPC1 | Chemistry; Metallurgy | 0 | Active |
| US10294294B2 | Synthetic antibodies to BAX and uses thereof | Physics | 0 | Active |
| US10435461B2 | Therapy for filovirus infection | Chemistry; Metallurgy | 0 | Active |
| US11352413B2 | Engineered PD-1 variants | Chemistry; Metallurgy | 0 | Active |
| US12162926B2 | Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins | Chemistry; Metallurgy | 0 | Active |
| US9360483B2 | Constructs and methods to identify antibodies that target glycans | Chemistry; Metallurgy | 0 | Active |
| US12202888B2 | High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US10759851B2 | Synthetic antibodies to BAX and uses thereof | Physics | 0 | Active |
| US11905322B2 | Engineered PD-1 variants | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.